MedPath

Umeclidinium Bromide/Vilanterol Trifenatate

Generic Name
Umeclidinium Bromide/Vilanterol Trifenatate
Clinical Trials
Related News

An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

Phase 4
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Drug: TIO/OLO
Drug: Albuterol/salbutamol
First Posted Date
2016-06-15
Last Posted Date
2018-07-02
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
236
Registration Number
NCT02799784
Locations
🇬🇧

GSK Investigational Site, Swinton, United Kingdom

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

Phase 3
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Drug: UMEC/VI matching placebo
Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)
First Posted Date
2014-10-06
Last Posted Date
2018-03-01
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
967
Registration Number
NCT02257385
Locations
🇸🇰

GSK Investigational Site, Vrable, Slovakia

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase 3
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Drug: Placebo
First Posted Date
2014-06-02
Last Posted Date
2017-11-09
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
498
Registration Number
NCT02152605
Locations
🇺🇦

GSK Investigational Site, Kyiv, Ukraine

Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPD

Phase 3
Completed
Conditions
COPD
Interventions
First Posted Date
2011-12-14
Last Posted Date
2017-08-15
Lead Sponsor
Queen's University
Target Recruit Count
17
Registration Number
NCT01491802
Locations
🇨🇦

Respiratory Investigation Unit at Kingston General Hospital, KIngston, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy